June 10, 2024
Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association
DUBLIN – June 10, 2024 – Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial
stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to attend the 84th Scientific Sessions of the American Diabetes Association in Orlando Florida, taking place on June 21- 24, 2024.